{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "L",
                    "alt": "P",
                    "position": "347"
                },
                "variant_string_id": "PINK1 L347P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss-of-function mutations in PINK1 and Parkin cause parkinsonism in humans and mitochondrial dysfunction in model organisms. Parkinson disease is associated with mitochondrial dysfunction, and PINK1 and Parkin are part of a pathway critical for maintaining mitochondrial integrity and function. Mitochondrial damage in the substantia nigra is linked to the pathogenesis of Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism as related to mitochondrial dysfunction and the role of PINK1 and Parkin in maintaining mitochondrial integrity, which is relevant to the functional assay of the variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study uses assays to assess the ability of disease - causing mutations in PINK1 to reconstitute YFP - Parkin recruitment to mitochondria in PINK1 - / - primary MEFs. This assay models the disruption of the PINK1/Parkin pathway which is central to the disease mechanism.",
                    "judgment": "Yes",
                    "reasoning": "The assay of reconstituting Parkin recruitment to mitochondria effectively reflects the disruption of the PINK1 - Parkin pathway in the context of the disease mechanism defined in Step 1.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The experiments involve transfection of mutant and wild - type PINK1 constructs into PINK1 - / - primary MEFs, treatment with CCCP, and assessment of YFP - Parkin recruitment to mitochondria by confocal microscopy. No information on basic controls, replicates, or variant controls is provided.",
                    "judgment": "No",
                    "reasoning": "There is no information indicating the use of basic controls (both normal/negative/wild type and abnormal/positive/null controls) and replicates, and no mention of variant controls. However, the assay of testing the ability of PINK1 mutants to reconstitute Parkin recruitment is a standard approach in the field.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The assay of testing the reconstitution of Parkin recruitment by PINK1 mutants is a standard approach to assess the functionality of PINK1 mutants in the context of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "Testing the ability of mutant proteins to reconstitute a key function in a known pathway is a broadly accepted approach in the field.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The L347P variant in PINK1 was tested for its ability to reconstitute Parkin recruitment to mitochondria. Although basic controls, replicates, and variant controls were not reported, the assay is a broadly accepted method in the field. Thus, the functional evidence strength is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "168"
                },
                "variant_string_id": "PINK1 A168P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss - of - function mutations in PINK1 and Parkin cause parkinsonism in humans and mitochondrial dysfunction in model organisms. The PINK1 - Parkin pathway is crucial for maintaining mitochondrial integrity and function, and mitochondrial dysfunction is linked to Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the disease mechanism related to mitochondrial dysfunction and the role of the PINK1 - Parkin pathway, which is relevant to the functional assessment of this variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study assesses the ability of the A168P mutant of PINK1 to reconstitute YFP - Parkin recruitment to mitochondria in PINK1 - / - primary MEFs, which models the disruption of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assay of reconstituting Parkin recruitment to mitochondria is relevant to the defined disease mechanism of disruption in the PINK1 - Parkin pathway.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The experiments involve transfection of the A168P PINK1 mutant into PINK1 - / - primary MEFs, treatment with CCCP, and assessment of YFP - Parkin recruitment to mitochondria by confocal microscopy. No details on basic controls, replicates, or variant controls are given.",
                    "judgment": "No",
                    "reasoning": "There is no information about the use of basic controls (both normal/negative/wild type and abnormal/positive/null controls), replicates, and variant controls. But the assay of testing PINK1 mutants' ability to reconstitute Parkin recruitment is a standard technique in the field.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Testing the ability of PINK1 mutants to reconstitute Parkin recruitment is a common approach to assess PINK1 functionality in the context of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "This type of assay is widely used and accepted in the field to study the function of PINK1 mutants.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The A168P variant in PINK1 was evaluated for its ability to reconstitute Parkin recruitment to mitochondria. Lacking information on basic controls, replicates, and variant controls, but the assay being a standard one in the field, the functional evidence strength is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "H",
                    "alt": "Q",
                    "position": "271"
                },
                "variant_string_id": "PINK1 H271Q"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss - of - function mutations in PINK1 and Parkin lead to parkinsonism and mitochondrial dysfunction. The PINK1 - Parkin pathway is important for mitochondrial integrity, and mitochondrial problems are associated with Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The disease mechanism related to mitochondrial dysfunction and the role of the PINK1 - Parkin pathway is clearly defined, which is relevant to the functional study of this variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study examines the ability of the H271Q mutant of PINK1 to reconstitute YFP - Parkin recruitment to mitochondria in PINK1 - / - primary MEFs, which is related to the disruption of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assay of reconstituting Parkin recruitment to mitochondria is applicable as it reflects the key PINK1 - Parkin pathway disruption in the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The experiment includes transfecting the H271Q PINK1 mutant into PINK1 - / - primary MEFs, treating with CCCP, and observing YFP - Parkin recruitment to mitochondria by confocal microscopy. No information on basic controls, replicates, or variant controls is provided.",
                    "judgment": "No",
                    "reasoning": "There is no indication of the use of basic controls, replicates, or variant controls. However, testing PINK1 mutants' ability to reconstitute Parkin recruitment is a standard approach in the field.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Testing PINK1 mutants for reconstituting Parkin recruitment is a well - established method to assess PINK1 function in the context of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "This assay is commonly used and accepted in the research on PINK1 and Parkin's role in Parkinson disease.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "For the H271Q variant in PINK1, the assay of reconstituting Parkin recruitment to mitochondria lacked information on basic controls, replicates, and variant controls. But being a standard assay in the field, the functional evidence strength is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "D",
                    "position": "309"
                },
                "variant_string_id": "PINK1 G309D"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Mutations in PINK1 and Parkin cause parkinsonism and mitochondrial dysfunction. The PINK1 - Parkin pathway is essential for maintaining mitochondrial integrity, and mitochondrial dysfunction is linked to Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The disease mechanism centered around mitochondrial dysfunction and the PINK1 - Parkin pathway is clearly defined, relevant to the functional assessment of this variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study assesses the ability of the G309D mutant of PINK1 to reconstitute YFP - Parkin recruitment to mitochondria in PINK1 - / - primary MEFs, which is related to the disruption of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assay of reconstituting Parkin recruitment to mitochondria effectively models the disruption of the PINK1 - Parkin pathway as defined in the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The experiment involves transfecting the G309D PINK1 mutant into PINK1 - / - primary MEFs, treating with CCCP, and observing YFP - Parkin recruitment to mitochondria by confocal microscopy. No details on basic controls, replicates, or variant controls are given.",
                    "judgment": "No",
                    "reasoning": "There is no information about basic controls, replicates, or variant controls. But testing PINK1 mutants' ability to reconstitute Parkin recruitment is a standard practice in the field.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Testing PINK1 mutants' ability to reconstitute Parkin recruitment is a widely recognized method to study PINK1 function in the context of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "This type of assay is commonly used and accepted in the field of Parkinson disease research related to PINK1 and Parkin.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The G309D variant in PINK1 was studied for its ability to reconstitute Parkin recruitment to mitochondria. With no information on basic controls, replicates, and variant controls, but the assay being a standard one in the field, the functional evidence strength is PS3_supporting."
        },
        {
            "variant_id": {
                "Gene": "PINK1",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "S",
                    "position": "411"
                },
                "variant_string_id": "PINK1 G411S"
            },
            "functional_evidence_aim": "Benign",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Loss - of - function mutations in PINK1 and Parkin cause parkinsonism and mitochondrial dysfunction. The PINK1 - Parkin pathway is crucial for mitochondrial integrity, and mitochondrial problems are associated with Parkinson disease.",
                    "judgment": "Yes",
                    "reasoning": "The disease mechanism related to mitochondrial dysfunction and the PINK1 - Parkin pathway is clearly defined, relevant to the functional study of this variant.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study assesses the ability of the G411S mutant of PINK1 to reconstitute YFP - Parkin recruitment to mitochondria in PINK1 - / - primary MEFs, which is related to the function of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assay of reconstituting Parkin recruitment to mitochondria is applicable as it reflects the function of the PINK1 - Parkin pathway in the context of the disease mechanism.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "The experiment includes transfecting the G411S PINK1 mutant into PINK1 - / - primary MEFs, treating with CCCP, and observing YFP - Parkin recruitment to mitochondria by confocal microscopy. No information on basic controls, replicates, or variant controls is provided.",
                    "judgment": "No",
                    "reasoning": "There is no indication of basic controls, replicates, or variant controls. However, testing PINK1 mutants' ability to reconstitute Parkin recruitment is a standard approach in the field.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Testing PINK1 mutants for reconstituting Parkin recruitment is a well - established method to assess PINK1 function in the context of the PINK1 - Parkin pathway.",
                    "judgment": "Yes",
                    "reasoning": "This assay is commonly used and accepted in the research on PINK1 and Parkin's role in Parkinson disease.",
                    "next_step_or